Related Experiment Videos
Primary sclerosing cholangitis. Requiem for biliary drainage operations?
E R Lemmer1, P C Bornman, J E Krige
1Gastrointestinal Clinic, Groote Schuur Hospital, University of Cape Town, South Africa.
Archives of Surgery (Chicago, Ill. : 1960)
|July 1, 1994
Summary
Primary sclerosing cholangitis (PSC) is a progressive liver disease with a poor prognosis. Elevated bilirubin levels at diagnosis predict a worse outcome, suggesting liver transplantation over surgery for advanced cases.
Area of Science:
- Hepatology
- Gastroenterology
- Surgical Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by bile duct inflammation and strictures.
- The long-term prognosis and optimal management strategies for PSC remain areas of active investigation.
Purpose of the Study:
- To evaluate the prognostic factors in patients with PSC.
- To assess the impact of surgical interventions on the outcomes of PSC patients.
Main Methods:
- A case series of 36 patients diagnosed with PSC between 1981 and 1991 at a tertiary referral center.
- Prospective follow-up of 32 patients for up to 9 years, defining outcomes as good (stable/slowly progressive) or poor (death/liver transplantation).
Main Results:
- Actuarial survival at 5 years was 52%, with 7 deaths and 2 liver transplants during follow-up.
- Elevated serum bilirubin concentration at presentation was the sole independent predictor of a poor outcome.
- Biliary drainage operations for obstructive jaundice did not prevent disease progression; liver transplantation was successful in end-stage disease.
Conclusions:
- Symptomatic PSC is a progressive condition with a generally poor prognosis.
- For PSC patients with advanced liver disease, liver transplantation should be considered a primary treatment option over biliary bypass surgery.